Healthcare & Life Sciences

Executing a mergers and acquisitions, M&A strategy without disrupting business operations requires the counsel of advisors with specialized technical expertise, extensive contacts, industry knowledge and a proven track record of successfully negotiating and closing deals.

Our Life Sciences and Healthcare division provides strategic guidance through the merger and acquisition process across a broad spectrum of health services industries:

  • Medical Devices & Equipment
  • Healthcare Technology
  • Biotech & Pharmaceuticals
  • Life Science Tools & Diagnostics
  • Contract Research Services

Our Services

David H. Crean

David H. Crean Business PortraitDavid H. Crean, Ph.D is a Managing Director at Objective Capital Partners where he leads the firm’s life science investment banking transactions. Dr. Crean has in excess of 20 years of life science R&D and corporate development transactional experience in the pharmaceutical industry where he is responsible for leading mergers, acquisitions, licensing and collaborations, and establishing corporate strategy. Dr. Crean’s transaction experience in the life sciences sector includes sell-side, buy-side, licensing and capital raising activities.

Life Sciences & Healthcare Executive Summary

For more information, download our Life Sciences & Healthcare PDF or contact David H. Crean at


Warning: extract() expects parameter 1 to be array, string given in /home/content/87/10888987/html/wp/wp-content/plugins/professional-linkedin-widget/professional-linkedin-widget.php on line 222